Next |
home / stock / vxrt / vxrt message board
Subject | By | Source | When |
---|---|---|---|
$VXRT Vaxart Inc | mick | investorshub | 04/30/2023 9:08:27 PM |
disappointing $VXRT | mick | investorshub | 04/15/2023 3:12:46 PM |
$VXRT Vaxart Inc | mick | investorshub | 02/27/2023 12:07:52 AM |
$VXRT Vaxart Inc | mick | investorshub | 02/06/2023 12:26:04 AM |
Too quiet here? The Bill and Melinda | Chuck8032 | investorshub | 01/31/2023 3:50:21 PM |
znewcar1: $VXRT 22% v4,160M C.9494 f131,25M H.9645 ml.7316 | znewcar1 | investorshangout | 12/29/2022 9:21:39 PM |
$VXRT Vaxart Inc | mick | investorshub | 12/18/2022 11:27:33 PM |
znewcar1: $VXRT 11% v3,8M c1.30 f131,25M H1.3 ML1.11 | znewcar1 | investorshangout | 12/02/2022 11:36:07 PM |
vxrt has style | mick | investorshub | 11/12/2022 6:49:33 PM |
$VXRT Scooped some up at $1.56 and closed | TommyBoyTrader9460 | investorshub | 11/12/2022 11:14:29 AM |
yes ya right on | mick | investorshub | 11/03/2022 11:43:18 PM |
Vaxart not doing well so it seems | Tamtam | investorshub | 11/03/2022 10:55:38 PM |
https://www.stockscores.com/charts/charts/?ticker=vxrt | mick | investorshub | 10/23/2022 6:34:43 PM |
whytestocks: $VXRT News Article - Vaxart to Host Third Quarter 2022 Business Update and Financial Re | whytestocks | investorshangout | 10/20/2022 3:45:52 PM |
$VXRT Vaxart Inc | Tamtam | investorshub | 09/08/2022 10:45:13 PM |
whytestocks: $VXRT News Article - Vaxart to Present at the H.C. Wainwright 24th Annual Global Invest | whytestocks | investorshangout | 09/07/2022 12:50:53 PM |
$VXRT Vaxart Inc | mick | investorshub | 08/31/2022 10:54:32 PM |
Current Report Filing (8-k) | Tamtam | investorshub | 08/08/2022 9:42:29 PM |
whytestocks: $VXRT News Article - Vaxart Provides New Update on Proxy Voting and Urges All Stockhold | whytestocks | investorshangout | 07/27/2022 12:30:54 PM |
Vaxart Publishes Clinical Data Suggesting its Oral COVID-19 | Tamtam | investorshub | 07/20/2022 11:51:22 PM |
News, Short Squeeze, Breakout and More Instantly...
Vaxart, Inc. (NASDAQ:VXRT) reported its first-quarter financial results after the bell Monday. Here's a look at the details. The Details...
Positive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b study evaluating Vaxart’s oral pill XBB COVID-19 vaccine a...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...